Skip to content

Quercetin supplementation in adolescents with familial hypercholesterolaemia (FH)

The effect of quercetin supplementation in adolescents with familial hypercholesterolaemia (FH) on flow mediated dilatation of the brachial artery

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001108606
Enrollment
10
Registered
2014-10-20
Start date
2014-11-03
Completion date
2015-06-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project aims to investigate the potential beneficial effect of a natural plant food compound (quercetin), on blood vessel function in adolescents with Familial Hypercholesterolaemia (FH). FH is a common genetic disorder affecting many thousands of children and adolescents throughout Australia, that elevates blood cholesterol from the time of birth, predisposing them to heart disease in early adult life. Untreated, 50% of men and 20% of women will have suffered a fatal or non-fatal cardiovascular event (ie heart attack) by the age of 50. Children with FH have highly compromised blood vessel function. Whilst medications like statins will lower cholesterol levels and can help improve blood vessel function, there is general reluctance among physicians and parents to commence children with FH on statins before the age of 18 years, because of a lack of long-term follow up studies on the use of these medications in younger patients. Thus, a nutrition-based supplement that could improve blood vessel function in children and adolescents with FH prior to them going on long term statin therapy would be of benefit. Using non-invasive ultrasound, we will investigate the effect of consuming a drink containing the natural plant food compound quercetin on how the blood vessel functions in 10 adolescents with FH aged 13-18 years. This will be compared to a placebo drink that contains a harmless sugar compound. We expect that the plant food compound will have a beneficial effect on blood vessel function in this population and lead to a potential new treatment option.

Interventions

Following an overnight fast, participants will undergo baseline measurements of endothelial function, before receiving oral quercetin aglycone (300mg dissolved in water). There will be a 7-day washout period between the intervention and control.

Sponsors

Dr Andrew Martin
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

Adolescents with familial hypercholesterolaemia

Exclusion criteria

Participant or legal guardian/parent unable to provide an informed consent.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026